期刊
BIOORGANIC & MEDICINAL CHEMISTRY
卷 23, 期 8, 页码 1691-1700出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2015.03.012
关键词
Triazine-benzimidazole hybrids; Anticancer; DHFR; DNA interaction; Molecular modelling
资金
- SERC Fast Track Research Grant, Department of Science and Technology, New Delhi [SR/FT/CS-40/2010]
- DST/Inspire Fellowship [IF110542]
A new series of triazine-benzimidazole hybrids has been synthesized with different substitution of primary and secondary amines at one of the position of triazine in moderate to good yields. These compounds were evaluated for their inhibitory activities over 60 human tumor cell lines at one dose and five dose concentrations. Compounds 6b, 8 and 9 showed broad spectrum of antitumor activities with GI(50) values of 9.79, 2.58 and 3.81 mu M, respectively. DNA binding studies also indicated strong interaction properties of these compounds. These synthesized compounds also showed inhibition of mammalian dihydrofolate reductase (DHFR). Compound 6b was depicted as the most active member of DHFR inhibitor with IC50 value of 1.05 mu M. Molecular modelling studies were used to identify the stabilized interactions of Compound 6b within the active site of enzyme for DHFR. (C) 2015 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据